Study guide

9.2 Quality Control Statistics, Levey-Jennings Charts & Westgard Multirules

ASCP Hematology Technologist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Hematopoiesis & Cellular Physiology

1.1 Hematopoiesis, Bone Marrow Microenvironment & Growth Factors 1.2 Erythrocyte Physiology, Metabolism & Destruction Pathways 1.3 Leukocyte Kinetics, Morphology & Phagocytic Function 1.4 Platelet Physiology, Ultrastructure & Thrombopoiesis

2 Chapter 2: Erythrocyte Disorders & Non-Hemolytic Anemias

2.1 Iron Metabolism & Iron Deficiency Anemia 2.2 Anemia of Chronic Inflammation, Sideroblastic Anemias & Lead Toxicity 2.3 Hemoglobinopathies & Qualitative Globin Chain Defects 2.4 Alpha and Beta Thalassemias 2.5 Megaloblastic, Macrocytic & Hypoproliferative Anemias

3 Chapter 3: Hemolytic Anemias & Erythrocytosis

3.1 Intrinsic Hemolytic Anemias: Membrane & Metabolic Defects 3.2 Immune-Mediated Hemolytic Anemias & Paroxysmal Nocturnal Hemoglobinuria 3.3 Non-Immune Extrinsic Hemolytic Anemias & Microangiopathies 3.4 Polycythemia & Erythrocytosis Classification

4 Chapter 4: Benign Leukocyte Alterations, Acute Leukemias & Bone Marrow Evaluation

4.1 Quantitative Leukocyte Alterations, Toxic Change & Leukemoid Reaction 4.2 Inherited Leukocyte Anomalies, Reactive Lymphocytosis & Storage Disorders 4.3 Acute Myeloid Leukemia (AML) & Related Neoplasms 4.4 Acute Lymphoblastic Leukemia (ALL) & Precursor Lymphoid Neoplasms 4.5 Bone Marrow Examination, Differential & M:E Ratio Assessment

5 Chapter 5: Chronic Myeloid Neoplasms, MDS & Mature Lymphoid Neoplasms

5.1 Myelodysplastic Syndromes (MDS) & Overlap Syndromes 5.2 Chronic Myeloproliferative Neoplasms (CML, PV, ET, PMF) 5.3 Chronic Lymphocytic Leukemia & Indolent B-Cell Lymphomas 5.4 Aggressive Lymphomas, Hodgkin Lymphoma & Mature T-Cell Disorders 5.5 Plasma Cell Neoplasms & Monoclonal Gammopathies

6 Chapter 6: Hemostasis: Primary, Secondary & Fibrinolytic Systems

6.1 Primary Hemostasis, Platelet Receptors & Qualitative Platelet Disorders 6.2 Quantitative Platelet Disorders & Immune Thrombocytopenias 6.3 The Coagulation Cascade & Cell-Based Hemostatic Model 6.4 Fibrinolytic System, Natural Anticoagulants & Thrombophilia

7 Chapter 7: Factor Deficiencies, Coagulation Testing & Anticoagulation

7.1 Hereditary Coagulation Factor Deficiencies & von Willebrand Disease 7.2 Acquired Coagulation Factor Deficiencies, Circulating Inhibitors & DIC 7.3 Routine and Specialized Coagulation Testing & Mixing Study Interpretation 7.4 Anticoagulant Therapies, Laboratory Monitoring & Reversal Strategies 7.5 Viscoelastic Testing, Heparin Neutralization & Chromogenic Assays

8 Chapter 8: Hematology Laboratory Testing & Advanced Diagnostics

8.1 Automated Hematology Analyzers, Interference Flags & Manual Methods 8.2 Cytochemical Staining, Flow Cytometry & Molecular Diagnostics 8.3 Erythrocyte Sedimentation Rate, Hemolytic Indicators & Special Erythrocyte Studies 8.4 Cerebrospinal Fluid Analysis, Cell Counts & Cytology 8.5 Serous Effusions & Synovial Fluid Analysis

9 Chapter 9: Laboratory Operations, Quality Assessment & Safety

9.1 The Total Testing Process: Preanalytical, Analytical & Postanalytical Quality 9.2 Quality Control Statistics, Levey-Jennings Charts & Westgard Multirules 9.3 Laboratory Mathematics: Dilutions, Concentration, Molarity & Standard Curves 9.4 Method Evaluation, Diagnostic Statistics & Point-of-Care Testing 9.5 Regulatory Framework, Proficiency Testing & Competency Assessment 9.6 Laboratory Safety: Bloodborne Pathogens, Personal Protective Equipment & Chemical Hygiene 9.7 Emergency Response, Spill Management & Specimen Packaging and Transport 9.8 Hematology Instrumentation: Microscopy, Counters, Analyzers & Centrifuges

9.2 Quality Control Statistics, Levey-Jennings Charts & Westgard Multirules

Key Takeaways Explain This Topic AI

Accuracy is closeness to the true value and is tracked by the mean; precision is reproducibility and is tracked by the standard deviation and the coefficient of variation, which is the only fair comparison across analytes.

In a Gaussian distribution about 68% of values fall within 1s, 95.5% within 2s, and 99.7% within 3s, so roughly 1 control in 20 exceeds 2s by chance, which is why 1_2s is a warning rule rather than a rejection rule.

Random error is detected by 1_3s and R_4s and raises the standard deviation; systematic error is detected by 2_2s, 4_1s, and 10x and moves the mean, appearing as an abrupt shift or a gradual trend.

A shift points to a discrete event such as a new reagent lot or recalibration; a trend points to something changing slowly such as reagent deterioration, lamp aging, or deposit buildup.

Bull's moving average (XB) uses batches of about 20 patient specimens to monitor MCV, MCH, and MCHC for analytical drift, and supplements rather than replaces commercial quality control.

Last updated: August 2026

Quality Control Statistics, Levey-Jennings Charts & Westgard Multirules

Quality control answers one question: is the measurement system still performing the way it did when it was validated? The ASCP BOC expects candidates to compute and interpret the descriptive statistics, read a Levey-Jennings chart, apply the Westgard multirules, and distinguish random from systematic error.

Accuracy, Precision, and the Four Measures of Center and Spread

Accuracy is closeness to the true value and is monitored by the mean . Precision is reproducibility and is monitored by the standard deviation and coefficient of variation . A method can be precise but inaccurate (tight cluster, wrong place) or accurate but imprecise (scattered around the correct value).

  • Statistic Definition Laboratory Use
  • Mean Arithmetic average of all values Target value of a control; measure of central tendency and accuracy

Median Middle value when data are ranked Preferred when the distribution is skewed or contains outliers, as in turnaround time data and many reference interval studies

Mode Most frequently occurring value Describes multi-peaked data, for example a bimodal red cell volume histogram

Standard deviation (s) s = ∑ ( x i − x ˉ ) 2 n − 1 s=\sqrt{\dfrac{\sum(x_i-\bar{x})^2}{n-1}} s = n − 1 ∑ ( x i ​ − x ˉ ) 2 ​ ​ Absolute dispersion; sets the control limits

Coefficient of variation % C V = s x ˉ × 100 \%CV=\dfrac{s}{\bar{x}}\times 100 % C V = x ˉ s ​ × 100 Relative dispersion; the only fair way to compare precision between analytes or concentration levels

Confidence interval Mean ± z × s \pm z\times s ± z × s Approximately 68% of values fall within ± 1 s \pm 1s ± 1 s , 95.5% within ± 2 s \pm 2s ± 2 s , and 99.7% within ± 3 s \pm 3s ± 3 s in a Gaussian distribution

Because 95.5% of results fall within two standard deviations, roughly 1 control value in 20 will exceed ± 2 s \pm 2s ± 2 s by chance alone . That is exactly why 1 2 s 1_{2s} 1 2 s ​ is a warning and not a rejection rule.

  • Core Statistical Measures
  • Fundamental Statistical Formulas

Mean ( x ˉ \bar{x} x ˉ ): Measure of central tendency (accuracy): x ˉ = ∑ x i n \bar{x} = \frac{\sum x_i}{n} x ˉ = n ∑ x i ​ ​

Standard Deviation ( s s s or SD \text{SD} SD ): Measure of dispersion (precision/reproducibility): s = ∑ ( x i − x ˉ ) 2 n − 1 s = \sqrt{\frac{\sum (x_i - \bar{x})^2}{n - 1}} s = n − 1 ∑ ( x i ​ − x ˉ ) 2 ​ ​

Coefficient of Variation ( % CV \text{\% CV} % CV ): Relative standard deviation independent of concentration unit: % CV = ( s x ˉ ) × 100 \text{\% CV} = \left( \frac{s}{\bar{x}} \right) \times 100 % CV = ( x ˉ s ​ ) × 100

Levey-Jennings Charts & Westgard Multirule Algorithm

Quality control data are plotted sequentially on Levey-Jennings control charts against established mean and standard deviation limits ( ± 1 s , ± 2 s , ± 3 s \pm 1s, \pm 2s, \pm 3s ± 1 s , ± 2 s , ± 3 s ):

1 2 s 1_{2s} 1 2 s ​ (Warning Rule): One control value exceeds ± 2 s \pm 2s ± 2 s . This is a screening warning; patient testing may continue while other rules are evaluated.

1 3 s 1_{3s} 1 3 s ​ (Rejection Rule): One control value exceeds ± 3 s \pm 3s ± 3 s . Rejects the run for Random Error (or severe systematic shift).

2 2 s 2_{2s} 2 2 s ​ (Rejection Rule): Two consecutive control observations exceed the same + 2 s +2s + 2 s or − 2 s -2s − 2 s limit. Rejects the run for Systematic Error .

R 4 s R_{4s} R 4 s ​ (Rejection Rule): One control exceeds + 2 s +2s + 2 s and another exceeds − 2 s -2s − 2 s in the same analytical run (a span of ≥ 4 s \ge 4s ≥ 4 s ). Rejects the run for Random Error .

4 1 s 4_{1s} 4 1 s ​ (Rejection Rule): Four consecutive control values exceed + 1 s +1s + 1 s or − 1 s -1s − 1 s on the same side of the mean. Rejects the run for Systematic Error .

10 x ˉ 10_{\bar{x}} 1 0 x ˉ ​ (Rejection Rule): Ten consecutive control values fall on one side of the mean. Rejects the run for Systematic Error .

Shifts versus Trends

Shift: An abrupt, permanent step-change in the control mean. Caused by: introduction of a new uncalibrated reagent lot, incorrect calibrator assignment, sudden optical alignment change, or major temperature fluctuation.

Trend: A gradual, progressive drift of control values in one direction over days/weeks. Caused by: reagent expiration/deterioration, light source aging (photometer bulb decay), gradual protein accumulation in flow cell/aperture, or aging electrode membranes.

Delta Checks & Critical Value Protocols

Delta Checks: Automated laboratory information system (LIS) algorithms comparing a patient's current test result with their previous recent result. Flags severe, physiologically improbable discrepancies to detect specimen misidentification, IV fluid contamination, or acute occult hemorrhage.

Critical Value Reporting: Critical test values (e.g., Platelets < 20 × 10 9 / L \text{Platelets} < 20 \times 10^9/\text{L} Platelets < 20 × 1 0 9 / L , WBC > 50.0 × 10 9 / L \text{WBC} > 50.0 \times 10^9/\text{L} WBC > 50.0 × 1 0 9 / L , Hb < 6.0 g/dL \text{Hb} < 6.0\text{ g/dL} Hb < 6.0 g/dL , or intracellular microorganisms in sterile body fluids) mandate immediate direct verbal notification to the licensed caregiver, mandatory read-back of patient identifiers and results, and full LIS documentation (date, exact time, staff name, recipient name).

Random versus Systematic Error

  • Feature Random Error Systematic Error
  • Appearance on the chart Scattered, unpredictable outliers A shift (abrupt step) or a trend (gradual drift)

Rules that detect it 1 3 s 1_{3s} 1 3 s ​ , R 4 s R_{4s} R 4 s ​ 2 2 s 2_{2s} 2 2 s ​ , 4 1 s 4_{1s} 4 1 s ​ , 10 x ˉ 10_{\bar{x}} 1 0 x ˉ ​

Statistic affected Standard deviation and CV rise Mean moves

Typical causes Bubbles, clots, short sampling, unstable power, imprecise pipetting New reagent lot, miscalibration, deteriorating reagent, aging lamp, drifting temperature

Quality Control Practice in Hematology

Frequency. CLIA requires at least two levels of control every 24 hours for most nonwaived tests; most hematology laboratories run three levels (low, normal, high) each shift, plus after maintenance, after a reagent lot change, and after any repair.

Corrective action. When a run is rejected the results are not reported . The technologist identifies the cause, corrects it, repeats the controls, and repeats patient testing; every step is documented. Repeating the control until it passes without identifying a cause is a documented CLIA deficiency.

Moving average (Bull's algorithm, XB). Hematology has a patient-based control unique to the discipline: the red cell indices MCV, MCH, and MCHC are stable in a population, so a smoothed moving average of batches of 20 patient samples detects analytical drift even between control runs. It monitors calibration stability, not individual patient accuracy.

Delta checks and specimen-level checks supplement, but never replace, statistical quality control.

Calibration verification confirms that the reportable range remains valid and is performed at least every six months, after major maintenance, and when controls show unexplained drift.